Edible Fish Feast Beats Malaria
March 08, 2017
The emerging threat of pesticide resistance means that biological malaria
control methods are once again in vogue. New research published in the
online open access journal BMC Public Health shows how Nile tilapia, a fish
more commonly served up to Kenyan diners, is a valuable weapon against
malaria mosquitoes.
Annabel Howard and Francois Omlin from the International Centre of Insect
Physiology and Ecology in Nairobi, Kenya, introduced Nile tilapia
(Oreochromis niloticus L.), to abandoned fishponds in western Kenya. The
study, funded by the Government of Finland, BioVision Foundation
(Switzerland) and the Toyota Environment Foundation, monitored pond life,
comparing the restocked ponds with a control pond nearby.
After 15 weeks the fish reduced both Anopheles gambiae s.l. and Anopheles
funestus, the region's primary malaria vectors, by over 94 percent. The fish
also decimated three quarters of the culicine mosquito population.
The findings present a win-win situation for Kenyans, who can use the fish
to limit mosquito populations and gain food and income from them too. "O.
niloticus fish were so effective in reducing immature mosquito populations
that there is likely to be a noticeable effect on the adult mosquito
population in the area," Howard says. This control method is apparently
sustainable, as the fish breed and provide a continuous population. The
authors also point out other benefits in their article.
There are over 2000 pediatric malaria cases annually in the Kisii Central
District where the authors carried out their research. Nile tilapia's
predilection for mosquitoes has been known since 1917. However this is the
first field data published detailing this species' use for mosquito control.
"Malaria mosquito control using edible fish in western Kenya: preliminary
findings of a controlled study"
Annabel FV Howard, Guofa Zhou and Francois X Omlin
BMC Public Health
biomedcentral/bmcpublichealth
BioMed Central is an independent online publishing house committed to
providing open access to peer-reviewed biological and medical research. This
commitment is based on the view that immediate free access to research and
the ability to freely archive and reuse published information is essential
to the rapid and efficient communication of science.
BioMed Central currently publishes over 160 journals across biology and
medicine. In addition to open-access original research, BioMed Central also
publishes reviews, commentaries and other non-original-research content.
Depending on the policies of the individual journal, this content may be
open access or provided only to subscribers.
biomedcentral